BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Germ cell tumor AND ELN, ENSG00000049540, 2006, WS, WBS, SVAS, FLJ43523, FLJ38671 AND Treatment
883 results:

  • 1. Prediction of disease recurrence in patients after complete pancreatic NET (PanNET) G2 resection.
    Olearska H; Sowa-Staszczak A; Morawiec-Sławek K; Kurzyńska A; Kolasa M; Tkacz E; Szumińska M; Hubalewska-Dydejczyk A; Opalinska M
    Endokrynol Pol; 2024; 75(1):102-108. PubMed ID: 38497396
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Long-term outcomes of multidisciplinary treatment combining surgery and stereotactic radiotherapy with Novalis for craniopharyngioma.
    Shinojima N; Yano S; Uchida D; Mizukami N; Mabe H; Kawashima J; Igata M; Kondo T; Uetani H; Yamamoto T; Uekawa K; Hide T; Mikami Y; Hirai T; Mukasa A
    J Clin Neurosci; 2024 Feb; 120():138-146. PubMed ID: 38244528
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. The reduced mortality of malignant melanoma at the population level is mainly attributable to treatment advances for the past decade.
    Li S; Tang T; Han J; Liu W; Chen R; Deng H; Jian T; Fu Z
    Cancer Epidemiol; 2024 Feb; 88():102515. PubMed ID: 38176331
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Significance of Social Determinants of Health in tumor Presentation, Hospital Readmission, and Overall Survival in Ocular Oncology.
    Choudhry HS; Patel AM; Nguyen HN; Kaleem MA; Handa JT
    Am J Ophthalmol; 2024 Apr; 260():21-29. PubMed ID: 37956780
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Sporadic vestibular schwannoma in a pediatric population: a case series.
    Kosaraju N; Moore LS; Mulders JY; Blevins NH
    Childs Nerv Syst; 2024 Mar; 40(3):635-645. PubMed ID: 37889276
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. treatment Course and Outcomes of Intracranial Teratomas in Pediatric Patients: A Retrospective 15-Year Case Series Study.
    Wu A; Jin MC; Vogel H; Hiniker S; Campen C; Prolo LM; Grant GA
    Pediatr Neurosurg; 2023; 58(6):429-438. PubMed ID: 37879310
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Survival outcomes and establishment of a novel risk stratification system in patients with ovarian yolk sac tumors.
    Li S; Zhang X; Zhang T; Zhang R; Cao D; Xiang Y; Yang J
    Gynecol Oncol; 2023 Nov; 178():145-152. PubMed ID: 37865050
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. The impact of changes in gadolinium-enhancement on disease progression in children with neurofibromatosis type 1-associated optic pathway glioma: a retrospective analysis.
    Kotch C; Si SJ; Desai K; Caminada P; Lo Russo FM; Li Y; Liu GT; Avery RA; Fisher MJ
    J Neurooncol; 2023 Sep; 164(3):741-747. PubMed ID: 37803102
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Quality of life after surgery for lower grade gliomas.
    Heffernan AE; Wu Y; Benz LS; Verhaak RGW; Kwan BM; Claus EB
    Cancer; 2023 Dec; 129(23):3761-3771. PubMed ID: 37599093
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Carmustine wafer implantation for supratentorial glioblastomas, IDH-wildtype in "extreme" neurosurgical conditions.
    Roux A; Aboubakr O; Elia A; Moiraghi A; Benevello C; Fathallah H; Parraga E; Oppenheim C; Chretien F; Dezamis E; Zanello M; Pallud J
    Neurosurg Rev; 2023 Jun; 46(1):140. PubMed ID: 37329341
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Should Redo Surgery be Offered to Patients with Relapsed Glioblastoma? - Outcome Analyses of a Single Institution Comparative Cohort Study.
    Eltoukhy M; Kandula V; Joseph S; Albanese E; Giridharan S
    World Neurosurg; 2023 Aug; 176():e543-e547. PubMed ID: 37268188
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Neurosurgical morbidity in pediatric supratentorial midline low-grade glioma: Results from the german LGG studies.
    Weiß S; Thomale UW; Schulz M; Kandels D; Schuhmann MU; El Damaty A; Krauss J; Driever PH; Witt O; Bison B; Pietsch T; Gnekow A; Simon M
    Int J Cancer; 2023 Oct; 153(8):1487-1500. PubMed ID: 37260252
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. A multi-institutional retrospective study of 340 cases of sinonasal malignant tumor.
    Tsuji T; Asato R; Kada S; Kitamura M; Tamaki H; Mizuta M; Tanaka S; Watanabe Y; Hori R; Kojima T; Shinohara S; Takebayashi S; Maetani T; Harada H; Kitani Y; Kumabe Y; Tsujimura T; Honda K; Ichimaru K; Ushiro K; Omori K
    Auris Nasus Larynx; 2024 Feb; 51(1):86-98. PubMed ID: 37248104
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Spatial Gene Expression Analysis Reveals Characteristic Gene Expression Patterns of De Novo Neuroendocrine Prostate Cancer Coexisting with Androgen Receptor Pathway Prostate Cancer.
    Watanabe R; Miura N; Kurata M; Kitazawa R; Kikugawa T; Saika T
    Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240308
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Evolution in the management of vestibular schwannoma: a single-center 15-year experience.
    El Sayed Ahmad Y; Gallois Y; Sol JC; Boetto S; Attal J; Sabatier J; Debs R; Deguine O; Marx M
    Eur Arch Otorhinolaryngol; 2023 Nov; 280(11):4885-4894. PubMed ID: 37195345
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Survival of Patients With Neuroblastoma After Assignment to Reduced Therapy Because of the 12- to 18-Month Change in Age Cutoff in Children's Oncology Group Risk Stratification.
    Bender HG; Irwin MS; Hogarty MD; Castleberry R; Maris JM; Kao PC; Zhang FF; Naranjo A; Cohn SL; London WB
    J Clin Oncol; 2023 Jun; 41(17):3149-3159. PubMed ID: 37098238
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Survival in melanoma in the nordic countries into the era of targeted and immunological therapies.
    Tichanek F; Försti A; Hemminki A; Hemminki O; Hemminki K
    Eur J Cancer; 2023 Jun; 186():133-141. PubMed ID: 37068406
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. The mutational landscape of skull base and spinal chordomas and the identification of potential prognostic and theranostic biomarkers.
    Passeri T; Gutman T; Hamza A; Adle-Biassette H; Girard E; Beaurepere R; Tariq Z; Mariani O; Dahmani A; Bourneix C; Abbritti R; Driouch K; Bohec M; Servant N; Baulande S; Decaudin D; Guichard JP; Calugaru V; Feuvret L; Guinebretière JM; Champion L; Bièche I; Froelich S; Mammar H; Masliah-Planchon J
    J Neurosurg; 2023 Nov; 139(5):1270-1280. PubMed ID: 37029667
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Bevacizumab in real-life patients with recurrent glioblastoma: benefit or futility?
    Smolenschi C; Rassy E; Pallud J; Dezamis E; Copaciu R; Parker F; Garcia G; Lezghed N; Colomba E; Khettab M; Ammari S; Fekhi M; Martanovschi L; Benadhou L; Knafo S; Guyon D; Cheaib B; Dhermain F; Dumont SN
    J Neurol; 2023 May; 270(5):2702-2714. PubMed ID: 36813928
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Early-Stage Primary Lung Neuroendocrine tumors Treated With Stereotactic Body Radiation Therapy: A Multi-Institution Experience.
    Oliver DE; Laborde JM; Singh DP; Milano MT; Videtic GM; Williams GR; LaRiviere MJ; Chan JW; Peters GW; Decker RH; Samson P; Robinson CG; Breen WG; Owen D; Tian S; Higgins KA; Almeldin D; Jabbour SK; Wang F; Grass GD; Perez BA; Dilling TJ; Strosberg J; Rosenberg SA
    Int J Radiat Oncol Biol Phys; 2023 Jul; 116(4):849-857. PubMed ID: 36708788
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 45.